Thermo Fisher Launches In-Air SARS-CoV-2 Surveillance Solution
Thermo Fisher Scientific Inc. (Waltham, MA, USA) has launched the Thermo Scientific AerosolSense Sampler, a new surveillance solution designed to deliver fast and highly reliable insight into the presence of in-air pathogens, including SARS-CoV-2. More...25 Mar 2021
Pfizer Evaluates Oral COVID-19 Antiviral Therapy for Prescribing at First Sign of Infection Without Requiring Hospitalization
Pfizer Inc. (New York, NY, USA) is progressing to multiple ascending doses after completing the dosing of single ascending doses in a Phase 1 study in healthy adults to evaluate the safety and tolerability of an investigational, novel oral antiviral therapeutic for SARS-CoV-2, the virus that causes COVID-19. More...25 Mar 2021
Carolina Liquid Chemistries Offers FDA Emergency Use Authorized POC COVID-19/Flu A&B Combo Test
Carolina Liquid Chemistries, Corp. (CLC, Greensboro, NC, USA) has made yet another addition to its Point-of-Care product line by offering the Emergency Use Authorized Status COVID-19/Flu A&B Combo Test from LifeSign LLC (Skillman, NJ, USA). More...24 Mar 2021
Highly Accurate Prognostic Test Predicts Personalized Risk of Severe Illness Due to SARS-CoV-2 Virus
A highly accurate prognostic test that predicts personalized risk of severe illness due to SARS-CoV-2 virus could become an important tool to manage the uncertainty of daily life during the pandemic by identifying high-risk individuals and for those that cannot be vaccinated. More...24 Mar 2021
Ortho's VITROS SARS-CoV-2 Antigen Test for High-Volume Testing Receives FDA EUA for New Performance, Sensitivity Data
Ortho Clinical Diagnostics (Raritan, NJ, USA) has received authorization from the US Food and Drug Administration to update key claims for the VITROS SARS-CoV-2 Antigen Test, the first high-volume SARS-CoV-2 antigen assay to receive Emergency Use Authorization (EUA) in the US. More...24 Mar 2021
Regeneron’s Antibody Cocktail Reduces Hospitalization or Death by 70% in COVID-19 Patients
Regeneron Pharmaceuticals, Inc.’s (Tarrytown, NY, USA) investigational antibody cocktail of casirivimab and imdevimab reduced hospitalization or death by 70% in non-hospitalized patients with COVID-19 in Phase 3 trial. More...24 Mar 2021
Novel Oral COVID-19 Vaccine Has Implications for Ease of Administration Anytime and Anywhere
An oral COVID-19 vaccine that successfully produced antibodies in a pre-clinical study after a single dose could also be a good candidate for protection against SARS-CoV-2 variants due to triple antigen targeting. More...24 Mar 2021
Gold Member
12-Channel ECG
CM1200B
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Electric Cast Saw
CC4 System
New
In-Bed Scale
IBFL500
In Other News
Thermo Fisher Collaborates with Artificial to Accelerate COVID-19 Diagnostics
GE Healthcare’s New Wireless Pocket-Sized Ultrasound Enables Quick Lung Scans of COVID-19 Patients at POC
Small Device Has Big Implications for COVID-19 Monoclonal Antibody Treatments
Eurofins Launches Upgraded RT-PCR Kit for Identification of Mutations Associated With SARS-CoV-2 Variants of Concern
Low Cost Pinprick COVID-19 Test Detects SARS-CoV-2 Antibodies in Drop of Blood in Under an Hour
New Ultra-Absorptive Nanofiber Swabs Could Improve COVID-19 Test Sensitivity
Automated System for SARS-CoV-2 Analysis in Wastewater to Enable Early Detection of COVID-19 Prevalence and Mutants
AI-Powered COVID-19 Solution to Analyze Chest-CT Scans Reduces Turnaround Time, Finds Large-Scale Study
Targeting New Antibody Supersite Key to COVID-19 Immunity
Ultrasound Waves at Medical Imaging Frequencies Can Damage SARS-CoV-2 and Could Treat COVID-19
Aspirin’s Lung-Protective Effects Could Decrease Ventilation, ICU Admission and Death in COVID-19 Patients
BioMérieux BIOFIRE Respiratory 2.1 (RP2.1) Panel with SARS-CoV-2 Becomes First COVID-19 Diagnostic Test to Obtain De Novo FDA Authorization
Direct, Cost-Effective COVID-19 Tests Identify UK/South African SARS-CoV-2 Variant and Reduces Test Time from Days to Hours
Insights Into Never-Before Characterized Mechanism of Immune Activation Could Pave Way for Anti-COVID-19 Therapies
Rapid Saliva-Based Test for COVID-19 Antibodies Could Scale Up Testing to Track Spread of SARS-CoV-2
Roche Launches New SARS-CoV-2 Variant Test to Monitor Emerging Coronavirus Mutations
Advanced Machine Learning Algorithm Accurately Predicts Risk of COVID-19 Progressing to Severe Disease or Death
Snibe Diagnostic SARS-CoV-2 Antigen Assay Secures CE Mark
New Saliva-Based COVID-19 Test is Less Invasive, More Accessible and Delivers Accurate Results at Lower Cost
Non-Invasive Skin Swab Samples Enough to Quickly Detect COVID-19, Finds New Study
Blocking Folate Metabolism with Oral, Prophylactic Drugs Could Reduce Viral Replication in SARS-CoV-2 Infected Cells
Fujifilm Launches Highly-Sensitive, Rapid CE-Marked SARS-CoV-2 Antigen Test Based on Silver Halide Amplification Technology
New Compound Reduces Overactive Immune Response Linked to Severe COVID-19 Infections
